Cheap Custom-Made Versions of High-Cost Drugs Spur Backlash

A new kind of drugmaker is emerging to meet demand for lower-priced medicines by custom-making drugs, sparking pushback from federal health regulators and legal challenges from traditional pharmaceutical companies.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News